Dyadic Newsroom

HC Wainwright & Co. Reiterates Buy on Dyadic International, Maintains $6 Price Target

BenzingaNov 14 18:57

HC Wainwright & Co. Reiterates Buy on Dyadic International, Maintains $6 Price Target

BenzingaJul 8 18:27

Dyadic International Analyst Ratings

BenzingaJul 8 18:25

Dyadic International: A Buy Rating on Strong Partnership Prospects and Revenue Growth Potential

TipRanksJul 8 18:19

Analysts' Top Healthcare Picks: Anavex Life Sciences (AVXL), Dyadic International (DYAI)

TipRanksNov 21, 2023 19:40

Dyadic International Analyst Ratings

BenzingaNov 13, 2023 20:49

Dyadic International's Growth Prospects Bolstered by Vaccine Development Collaboration: A Buy Rating Reaffirmed

TipRanksOct 23, 2023 18:25

HC Wainwright & Co. Reiterates Buy on Dyadic International, Maintains $6 Price Target

BenzingaMay 24, 2023 18:41

H.C. Wainwright Keeps Their Buy Rating on Dyadic International (DYAI)

TipRanksMay 24, 2023 18:25

Analysts Offer Insights on Healthcare Companies: Dyadic International (DYAI), Biophytis (BPTS) and 2seventy Bio (TSVT)

TipRanksFeb 3, 2023 19:35

Dyadic International Analyst Ratings

Benzinga Analyst RatingsFeb 3, 2023 19:11

HC Wainwright & Co. Reiterates Buy on Dyadic International, Maintains $6 Price Target

Benzinga Real-time NewsFeb 3, 2023 19:11

Analysts Offer Insights on Healthcare Companies: Satsuma Pharmaceuticals (STSA) and Dyadic International (DYAI)

TipRanksNov 14, 2022 22:45